FIELD: veterinary medicine.
SUBSTANCE: method comprises carrying out serological studies and identifying animals reacting positively. Additionally, after carrying out of serological studies the preparation in the form of a mixture of the medical solution formaldehyde with isotonic sodium chloride solution is administered to the pigs of all age groups at a ratio of parts by weight 2-6:994-998. The preparation is administered twice intramuscularly at a dose of 5-6 ml per head with an interval of 7-8 days between injections. 10-12 days after the preparation is administered the additional serological studies are carried out and the infected animals are identified.
EFFECT: method enables to increase the percentage of identifying animals in relation to actinobacillus pleuropneumonia.
3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
STRAIN OF BACTERIA ACTINOBACILLUS PLEUROPNEUMONIAE SEROTYPE 8, INTENDED FOR PRODUCTION OF MONO- AND POLYVALENT IMMUNOGENIC COMPOSITIONS AIMED AT SPECIFIC PREVENTION OF PORCINE ACTINOBACILLUS PLEUROPNEUMONIAE | 2023 |
|
RU2824493C1 |
STRAIN Haemophilus parasuis SK-1 AS PATHOGEN OF SWINE HEMOPHILEOUS POLYSEROSITIS FOR PREPARING DIAGNOSTIC AND VACCINE PREPARATIONS | 2004 |
|
RU2268933C1 |
HAEMOPHILUS PARASUIS STRAIN AS PORCINE HAEMOPHYLIC POLYSEROSITIS AGENT FOR PRODUCTION OF DIAGNOSTIC AND VACCINE PREPARATIONS | 2004 |
|
RU2269570C2 |
VACCINE AGAINST INFECTIOUS ATROPHIC RHINITIS AND PASTERELLOSIS IN PIGS INACTIVATED, METHOD FOR ITS PREPARATION | 2021 |
|
RU2763991C1 |
VACCINE AIMED AGAINST ACTINOBACILLOUS PLEUROPNEUMONIA AND METHOD OF OBTAINING THEREOF | 2010 |
|
RU2554812C2 |
LIQUID NUTRIENT MEDIUM FOR BACTERIUM HAEMOPHILUS PLEUROPNEUMONIAE CULTURING | 1993 |
|
RU2076903C1 |
METHOD OF TREATMENT OF BRUCELLOSIS OF CATTLE | 2013 |
|
RU2540428C1 |
APPLICATION OF MELOXYCAM FOR TREATMENT OF RESPIRATORY DISEASES IN SWINE | 2005 |
|
RU2360680C2 |
VACCINE TO PROTECT PIGS FROM ACTINOBACILLUS PLEUROPNEUMONIAE | 2018 |
|
RU2750894C1 |
METHOD FOR REARING PIGLETS IN FARMS THAT ARE DISADVANTAGED IN TERMS OF HAEMOPHILOUS POLYSEROSITIS | 2021 |
|
RU2780858C1 |
Authors
Dates
2014-08-27—Published
2013-10-03—Filed